Description

Technical Parameters

GW501516 (cardiometabolic regulator) 10mg 100 tablets Core Information *

Pharmaceutical -grade raw materials | GW501516 (PPARδ agonist )

Chemical name : 2-(4-{2-[(1-phenylcyclohexyl)amino]ethoxy}phenyl)ethyl(phenyl)carbamate

CAS number : 317318-70-0

EINECS number : To be assigned

Molecular formula : C₂₁H₂₅FN₂O₃

Molecular weight : 364.43

Melting point : 138-140°C

Appearance : White crystalline powder

Purity : ≥98% (HPLC test)

Core Properties

GW501516 is a highly selective peroxisome proliferator-activated receptor δ (PPARδ) agonist . Due to its unique effects on regulating fat metabolism and enhancing endurance , it is widely used in metabolic disease research, athletic performance enhancement, and weight management research .

✅ Fat metabolism regulation mechanism :

PPARδ activation : Specific activation of PPARδ receptors to regulate fat metabolism gene expression

Fatty acid oxidation : Promotes fatty acid oxidation in skeletal muscle and adipose tissue

Energy consumption : Increase basal metabolic rate and promote energy consumption

✅ Sports performance improvement effect :

Endurance Enhancement : Preclinical studies show significant increases in aerobic exercise endurance time

Fat utilization : Increase fat energy supply ratio and conserve muscle glycogen reserves

Recovery acceleration : Reduces muscle damage and inflammation after exercise

✅ Metabolism-enhancing properties :

Blood lipid regulation : lower triglycerides and increase high-density lipoprotein levels

Insulin sensitivity : Improve insulin sensitivity and regulate blood sugar stability

Weight Management : Promotes fat loss and maintains lean body mass

Usage Protocol

1. Investigational Dosage Regimen :

Starting dose :

5 mg once a day

Continue for 1-2 weeks to assess tolerance

Maintenance dose :

10-20 mg/day, adjusted according to individual response

Maximum study dose: no more than 40 mg/day

2. When to use :

Use before exercise :

Take 60 minutes before exercise

Enhance aerobic endurance and fat utilization

Daily Use :

Take in the morning on an empty stomach

Promote daily fat metabolism and energy consumption

3. Cycle Management :

Research period :

Short-term studies: 4-8 weeks

Long-term studies: 8-12 weeks (close monitoring required)

Post- cycle observations :

Continue to observe for 2-4 weeks after stopping the drug

Monitor metabolic markers and body composition changes

Why choose GW501516 raw material?

Metabolic regulation : Unique PPARδ activation mechanism specifically regulates fat metabolism

Endurance Improvement : Significantly enhance aerobic endurance and fat utilization efficiency

Research value : Has important research value in the fields of metabolic diseases and sports medicine

Summarize

GW501516 is a key compound in the study of the PPARδ signaling pathway. Through scientific formulation techniques , it can be formulated into various dosage forms, including oral tablets . Choosing us ensures high-purity raw materials, professional technical support, and comprehensive after-sales service .

Need anything, please contact us